Optima Health plc (AIM:OPT)
London · Delayed Price · Currency is GBP · Price in GBX 247.50
-6.00 (-2.37%)
At close: Aug 14, 2026
Optima Health Cash Flow Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1.4 | 1.65 | -1.08 | 1.59 | -0.25 |
Depreciation & Amortization | 11.2 | 6.96 | 7.48 | 7.36 | 1.66 |
Other Amortization | - | 3.46 | 3.3 | 2.86 | 0.58 |
Loss (Gain) From Sale of Assets | 0.01 | 0.07 | 0 | 0.02 | - |
Stock-Based Compensation | 0.24 | 0.04 | - | - | - |
Other Operating Activities | -0.06 | -1.51 | -1.33 | -3.41 | -0.46 |
Change in Accounts Receivable | -1.85 | -0.28 | 2.35 | -6.64 | 1.41 |
Change in Inventory | -0.05 | -0.03 | 0.1 | -0.05 | 0 |
Change in Accounts Payable | 4.33 | -7.66 | 2.03 | 4.86 | -3.78 |
Operating Cash Flow | 15.24 | 2.69 | 12.85 | 6.59 | -0.84 |
Operating Cash Flow Growth | 467.18% | -79.08% | 94.83% | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -1.09 | -1.8 | -0.4 | -1.41 | -0.32 |
Sale of Property, Plant & Equipment | - | 0.03 | - | - | - |
Cash Acquisitions | -101.81 | -1.93 | - | 5.04 | 8.57 |
Sale (Purchase) of Intangibles | -2.04 | -1.96 | -2.45 | -2.47 | -0.48 |
Other Investing Activities | 0.06 | - | - | -0.32 | 0 |
Investing Cash Flow | -104.89 | -5.65 | -2.85 | 0.84 | 7.77 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 99 | 17 | - | - | - |
Long-Term Debt Repaid | -1.52 | -1.12 | -1.63 | -1.48 | -0.19 |
Net Debt Issued (Repaid) | 97.48 | 15.88 | -1.63 | -1.48 | -0.19 |
Issuance of Common Stock | - | 1.98 | - | - | - |
Other Financing Activities | -1.02 | -21.19 | - | -0.13 | -0.02 |
Financing Cash Flow | 96.46 | -3.34 | -1.63 | -1.61 | -0.21 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 0 | - | - | - | - |
Net Cash Flow | 6.81 | -6.3 | 8.37 | 5.82 | 6.73 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 14.15 | 0.89 | 12.44 | 5.18 | -1.15 |
Free Cash Flow Growth | 1486.32% | -92.83% | 140.22% | - | - |
Free Cash Flow Margin | 11.73% | 0.85% | 11.22% | 4.49% | -5.15% |
Free Cash Flow Per Share | 0.20 | 0.02 | - | - | - |
Levered Free Cash Flow | 20.85 | -1.47 | 15.52 | 12.19 | - |
Unlevered Free Cash Flow | 21.82 | -1.06 | 15.61 | 12.27 | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | - | 0.44 | - | 0.13 | 0.02 |
Cash Income Tax Paid | - | 2.69 | 1.9 | 2.6 | 0.18 |
Change in Working Capital | 2.44 | -7.97 | 4.48 | -1.82 | -2.37 |